Mayo Clinic appeared to be the Corporate Investor, which was created in 1919. The main department of described Corporate Investor is located in the Rochester. The company was established in North America in United States.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Mayo Clinic, startups are often financed by Canaan Partners, Social Capital, Three Arch Partners. The meaningful sponsors for the fund in investment in the same round are Three Arch Partners, MPM Capital, Bay City Capital. In the next rounds fund is usually obtained by Venrock, Three Arch Partners, Sands Capital Ventures.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Biopharma, Artificial Intelligence. Among the most popular portfolio startups of the fund, we may highlight Helix, DayTwo, AliveCor. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low.
The current fund was established by Augustus Stinchfield, Charles Horace Mayo, Christopher Graham, Donald Balfou, Henry Stanley Plummer, Melvin Millet, William James Mayo. We also calculated 8 valuable employees in our database.
The higher amount of exits for fund were in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 investment rounds annually. The real fund results show that this Corporate Investor is 8 percentage points less often commits exit comparing to other companies. The important activity for fund was in 2014. Despite it in 2019 the fund had an activity. The average startup value when the investment from Mayo Clinic is 50-100 millions dollars. This Mayo Clinic works on 17 percentage points less the average amount of lead investments comparing to the other organizations.
Related Funds
| Fund Name | Location |
| AdUX | France, Ile-de-France, Paris |
| Anomaly Ventures | - |
| Aurion Capital | Canada, Ontario, Toronto |
| BM&FBOVESPA S.A. | Brazil, São Paulo, Sao Paulo |
| Chromo Invest | Brazil, Porto Alegre, Rio Grande do Sul |
| Clermont Group | Central Region, Singapore, Singapore |
| Dynafund Ventures | California, Torrance, United States |
| Encourage Technologies | Hokkaido Prefecture, Japan, Sapporo |
| Frontive Holding Limited | - |
| IPB Capital | Central, Central Region, Singapore |
| Manuardeo | - |
| Mysteel Global | Baoshan, China, Shanghai |
| North Atlantic Capital | Maine, Portland, United States |
| Nounos Creamery | New York, New York, United States |
| RDseed | Israel, Tel Aviv, Tel Aviv District |
| Siemens Mustang Ventures | California, Santa Clara, United States |
| Socadif | - |
| Tata Consultancy Services | India, Maharashtra, Mumbai |
| Zhixin Zede Touzi | - |
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Clarapath | $36M | 24 Jul 2024 | New York, New York, United States | ||
DyaMX | $88M | 25 Jun 2024 | Minnesota, United States | ||
Nucleus RadioPharma | 05 Jun 2024 | Rochester, New York, United States | |||
PinkDx | $40M | 25 Apr 2024 | Indianapolis, Indiana, United States | ||
Collaborative Robotics | $100M | 10 Apr 2024 | Santa Clara, California, United States | ||
UpDoc | 05 Jan 2024 | Palo Alto, California, United States | |||
vMocion | $3M | 03 Jan 2024 | Los Angeles, California, United States | ||
Nucleus RadioPharma | $56M | 17 Oct 2023 | Rochester, New York, United States | ||
The Contract Network | $8M | 02 Aug 2023 | Atlanta, Georgia, United States |
– SimBioSys announced it raised $15m in Series A funding to accelerate the development and commercialization of its TumorScope software platform.
– The company’s novel, simulation-based, precision medicine platform enables individualized treatment planning for cancer patients.
– This Series A was co-led by Genoa Ventures and Northpond Ventures, with participation from AV8 Ventures, Heritage Medical Group, and Mayo Clinic.
– Existing investors and founders also participated in this financing round, bringing the company’s total capital raised to $21m.
– In the first half of 2021, SimBioSys tripled its headcount, bringing in expert clinicians, scientists, and executives from the life sciences industry.
– TripleBlind, a startup that has devised a way to encrypt data so that it can be shared without ever being decrypted or even leaving the data owner’s firewall, and keeping the whole process compliant with data protection regulations, raised $24m in Series A funding.
– The round was co-led by General Catalyst and the Mayo Clinic, with AVG Basecamp Fund, Accenture Ventures, Clocktower Technology Ventures, Dolby Family Ventures, Flyover Capital, KCRise Fund, NextGen Venture Partners and Wavemaker Three-Sixty Health also participating.
– The company estimates there are some 43 zetabytes of data stored by enterprises today globally that is not being used as it could be because of the limitations imposed both by these and other data protection rules, as well as general hesitancy over sharing IP and other issues around sharing data.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Clarapath | $36M | 24 Jul 2024 | New York, New York, United States | ||
DyaMX | $88M | 25 Jun 2024 | Minnesota, United States | ||
Nucleus RadioPharma | 05 Jun 2024 | Rochester, New York, United States | |||
PinkDx | $40M | 25 Apr 2024 | Indianapolis, Indiana, United States | ||
Collaborative Robotics | $100M | 10 Apr 2024 | Santa Clara, California, United States | ||
UpDoc | 05 Jan 2024 | Palo Alto, California, United States | |||
vMocion | $3M | 03 Jan 2024 | Los Angeles, California, United States | ||
Nucleus RadioPharma | $56M | 17 Oct 2023 | Rochester, New York, United States | ||
The Contract Network | $8M | 02 Aug 2023 | Atlanta, Georgia, United States |
